These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 3323172)

  • 1. Acute lymphoblastic leukemia of childhood.
    Steinherz PG
    Hematol Oncol Clin North Am; 1987 Dec; 1(4):549-66. PubMed ID: 3323172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Acute lymphoblastic leukemia in childhood: importance of sex as a prognostic factor (author's transl)].
    Kuchler H; Buriot D; Maier M; Griscelli C
    Arch Fr Pediatr; 1982 Jan; 39(1):17-21. PubMed ID: 6950692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Childhood acute lymphoblastic leukemia: current perspectives.
    Landier W
    Oncol Nurs Forum; 2001 Jun; 28(5):823-33; quiz 834-5. PubMed ID: 11421142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcome in children with relapsed ALL by risk-stratified salvage therapy: results of trial acute lymphoblastic leukemia-relapse study of the Berlin-Frankfurt-Münster Group 87.
    Einsiedel HG; von Stackelberg A; Hartmann R; Fengler R; Schrappe M; Janka-Schaub G; Mann G; Hählen K; Göbel U; Klingebiel T; Ludwig WD; Henze G
    J Clin Oncol; 2005 Nov; 23(31):7942-50. PubMed ID: 16258094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prognostic subgrouping and early or late intensification of the treatment of childhood acute lymphocytic leukemia].
    Fujimoto T
    Gan To Kagaku Ryoho; 1983 Jun; 10(6):1395-407. PubMed ID: 6603198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factor analysis in acute lymphocytic leukemia of childhood.
    Plüss HJ
    Helv Paediatr Acta; 1987 Oct; 42(2-3):197-247. PubMed ID: 3480281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of prognostic factors in improving the design and efficiency of clinical trials in childhood leukemia: Children's Cancer Study Group Report.
    Miller DR; Leikin S; Albo V; Vitale L; Sather H; Coccia P; Nesbit M; Karon M; Hammond D
    Cancer Treat Rep; 1980; 64(2-3):381-92. PubMed ID: 6931631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Childhood T-cell acute lymphoblastic leukemia: the Dana-Farber Cancer Institute acute lymphoblastic leukemia consortium experience.
    Goldberg JM; Silverman LB; Levy DE; Dalton VK; Gelber RD; Lehmann L; Cohen HJ; Sallan SE; Asselin BL
    J Clin Oncol; 2003 Oct; 21(19):3616-22. PubMed ID: 14512392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex and other prognostic factors in acute lymphoblastic leukemia in childhood.
    Gustafsson G; Kreuger A
    Am J Pediatr Hematol Oncol; 1983; 5(3):243-50. PubMed ID: 6578688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretreatment prognostic factors and hospitalization periods in childhood acute lymphoblastic leukemia.
    Ramot B; Modan M; Meerowitz Y; Potashnick D; Kende G; Berkowicz M
    Isr J Med Sci; 1982 Apr; 18(4):447-55. PubMed ID: 6953056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of high and low risk acute lymphoblastic leukemias in the child, with 2 modalities of preventive therapy on the central nervous system (Pethema 7/78 protocol)].
    Ortega Aramburu JJ; Javier G; Montagut JM; Torán N
    An Esp Pediatr; 1985 Nov; 23(6):417-30. PubMed ID: 3867301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.
    Attarbaschi A; Mann G; Panzer-Grümayer R; Röttgers S; Steiner M; König M; Csinady E; Dworzak MN; Seidel M; Janousek D; Möricke A; Reichelt C; Harbott J; Schrappe M; Gadner H; Haas OA
    J Clin Oncol; 2008 Jun; 26(18):3046-50. PubMed ID: 18565891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors for relapsed childhood acute lymphoblastic leukemia: impact of allogeneic stem cell transplantation--a report from the Kyushu-Yamaguchi Children's Cancer Study Group.
    Matsuzaki A; Nagatoshi Y; Inada H; Nakayama H; Yanai F; Ayukawa H; Kawakami K; Moritake H; Suminoe A; Okamura J
    Pediatr Blood Cancer; 2005 Aug; 45(2):111-20. PubMed ID: 15782402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors for long-term survival in leukemic marrow recipients with special emphasis on age and prophylaxis for graft-versus-host disease.
    Aschan J; Ringdén O
    Clin Transplant; 1994 Jun; 8(3 Pt 1):258-70. PubMed ID: 8061365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of childhood acute lymphoblastic leukemia after the first relapse: curative strategies.
    Uderzo C; Dini G; Locatelli F; Miniero R; Tamaro P
    Haematologica; 2000 Nov; 85(11 Suppl):47-53. PubMed ID: 11268324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Allogeneic bone marrow transplantation in acute lymphoblastic leukemia of children. Analysis of prognostic factors. GEGMO (Bone Marrow Study Group) study].
    Bordigoni P; Vernant JP; Souillet G; Philippe N; Maraninchi D
    Arch Fr Pediatr; 1986 Dec; 43(10):765-8. PubMed ID: 3548632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prognosis of acute lymphoblastic leukemia, developing isolated testicular involvement at late relapse].
    Arakawa S; Imashuku S; Nagai T; Morioka Y; Todo S; Ikuta H; Izumi H; Fujiwara F; Konishi K
    Rinsho Ketsueki; 1984 Aug; 25(8):1232-8. PubMed ID: 6595425
    [No Abstract]   [Full Text] [Related]  

  • 18. Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcome.
    Ballerini P; Landman-Parker J; Cayuela JM; Asnafi V; Labopin M; Gandemer V; Perel Y; Michel G; Leblanc T; Schmitt C; Fasola S; Hagemejier A; Sigaux F; Auclerc MF; Douay L; Leverger G; Baruchel A
    Haematologica; 2008 Nov; 93(11):1658-65. PubMed ID: 18835836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic effectiveness of the ALL-XH-99 protocol for childhood acute lymphoblastic leukemia.
    Wang YR; Jin RM; Xu JW; Xiao Y; Zhou DF; Zhang ZQ
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Feb; 10(1):1-4. PubMed ID: 18289459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor secretion is an independent prognostic factor for relapse-free survival in pediatric acute myeloid leukemia patients.
    de Bont ES; Fidler V; Meeuwsen T; Scherpen F; Hählen K; Kamps WA
    Clin Cancer Res; 2002 Sep; 8(9):2856-61. PubMed ID: 12231527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.